US/UK/Canada

Share

Contacts

  • Rikard Akhtarzand

    CEO


    Grev Turegatan 3, floor 4, SE 114 46 Stockholm, Sweden
    08 128 766 00
    http://www.addvisegroup.com

    • Quotes

    Strengthening ADDvise with Fredrik Mella enables us to continue to accelerate our growth rate. He will complement our management team with his international experience from the Medtech industry, and I believe Fredrik will be a good leader and coach for our subsidiaries' CEOs.
    Rikard Akhtarzand, CEO
    ADDvise is a successful company in the middle of an exciting growth journey. I look forward to make a difference and contribute with my experiences
    Fredrik Mella
    Pick a time period -
    Tags ( Active)

    ADDvise acquires Axelerist, Inc.

    ADDvise Group has entered into a share purchase agreement with the owner of Axelerist, Inc. (“Axelerist”) regarding the acquisition of all shares of Axelerist. Closing of the acquisition takes place today. Axelerist, based in Yorktown Heights, New York, is a leading provider of tailored rental and purchase solutions of MedTech- and laboratory equipment for clinical studies. Customers consist of contract research organisations (CRO) and biotech- and pharmaceutical companies. Axelerist’s revenue for the last twelve months per October 31, 2023, amounted to USD 8.7 million, with an EBITDA

    ADDvise Group successfully issues subsequent senior secured bonds of SEK 450 million

    ADDvise Group AB (publ) has successfully issued subsequent senior secured bonds of SEK 450 million under its existing bond loan with ISIN SE0020180271. Following the bond issue, in total SEK 1,450 million will be outstanding under the framework. The subsequent bonds was priced at 101.75% of par and carry a floating interest rate of STIBOR 3m plus 5.50 per cent per annum. The settlement date for the bond issue is expected to be 20 November 2023. The bond issue was met with strong demand from Nordic and international institutional investors and was upsized by SEK 50 million on the back of

    ADDvise Group contemplates issuance of subsequent bonds of SEK 400 million

    ADDvise Group AB (publ) has mandated Pareto Securities AB and Skandinaviska Enskilda Banken AB (publ) to arrange a series of credit investor meetings commencing on 30 October 2023. A subsequent issue of senior secured bonds in an expected amount of SEK 400 million under the company's existing senior secured bond loan with a framework of SEK 2,000 million (the "Bond Issue") may follow, subject to inter alia market conditions. The proceeds from the contemplated Bond Issue shall be used to finance general corporate purposes (including capital expenditures and acquisitions).   For

    ADDvise Group’s nomination committee for the Annual General Meeting 2024

    In accordance with the resolution at the Annual General Meeting 2022 of ADDvise Group, the nomination committee for the Annual General Meeting 2024 shall comprise of representatives of the three largest shareholders by votes, according to the shareholders’ register as of 30 June 2023 maintained by Euroclear Sweden, and of the chairman of the board of directors. The representative appointed by the largest shareholder by votes shall be appointed chairman of the nomination committee. The nomination committee has now been appointed and consists of the following members: · Per-Anders

    Interim report 2023, January 1-September 30

    July-September 2023 Net revenue for the period was SEK 321.1 million (237.0), an increase of 35.5%. Organic growth was 18.0%. Orders received for the period was SEK 360.0 million (268.4), an increase of 34.1%. Organic growth was 30.1%. EBITDA for the period was SEK 93.6 million (39.2) Profit/loss for the period was SEK 34.8 million (33.9) Earnings per share for the period amounted to SEK 0.19 (0.19) Cash flow from Operations for the period was SEK 28.9 million (18.3) January-September 2023 Net revenue for the period was SEK 976.0 million (631.3), an increase of 54.6%.

    Invitation to presentation of interim report July 1 – September 30, 2023

    ADDvise Group’s interim report for the period July 1 – September 30, 2023 will be published on October 26, 2023 at 07:45 (CEST). Investors, analysts and other stakeholders are invited to a webcast and conference call at 14:00 (CEST) / 08:00 AM (EST) the same day where CEO Rikard Akhtarzand and CFO Oliver Humlen will present the report.   Webcast If you wish to participate via webcast, please use the link below.   https://ir.financialhearings.com/addvise-group-q3-2023   Conference call If you wish to participate via conference call, please register via the link

    ADDvise acquires Kolplast CI S.A.

    ADDvise Group has entered into a share purchase agreement with the owners of Kolplast CI S.A. (“Kolplast”) regarding the acquisition of all shares of Kolplast in accordance with the letter of intent previously communicated. Closing of the acquisition is expected to take place during the fourth quarter of 2023.   Kolplast’s revenue for the last twelve months per August 31, 2023 amounted to BRL 101.9 million, with an EBITDA of BRL 29.8 million, corresponding to an EBITDA margin of 29.3 per cent. The acquisition will be consummated at an initial cash consideration of BRL 160 million and

    ADDvise decides not to complete the acquisition of X-Ray Cassette Repair Company, Inc.

    X-Ray Cassette Repair Company, Inc. which ADDvise signed a letter of intent to acquire on February 14, 2023, has during the subsequent due diligence not performed in line with initial expectations as regards sales and profitability. In view of this, ADDvise has decided not to complete the acquisition. As previously communicated, ADDvise is only announcing acquisitions in conjunction with signing of share purchase agreements. For further information, please contact: Rikard Akhtarzand, CEO+46 765-25 90 71rikard.akhtarzand@addvisegroup.se Important information This

    ADDvise Group’s CEO divests shares - remains a committed and long-term shareholder

    Rikard Akhtarzand, CEO of ADDvise Group AB (publ) (“ADDvise” or the “Company”), has informed the Company that he has sold 2,500,000 Class B shares in ADDvise, representing approximately 1.3% of total outstanding shares and 18.1% of his total shareholding in the Company, and that he has entered a 180-day lock-up agreement for his remaining shares. The shares were sold in a block trade to Swedish and international investors, including the Company’s Chairman Staffan Torstensson and largest owner Per Åhlgren. Following the transaction, Rikard Akhtarzand holds 2,620,416 Class A shares and 8 658

    ADDvise acquires Diabetic Supplies Inc.

    ADDvise Group has today entered into a share purchase agreement with the owners of Diabetic Supplies Inc. (“Diabetic Supplies”) regarding the acquisition of all shares of Diabetic Supplies in accordance with the letter of intent previously communicated. Closing of the acquisition is expected to take place at the beginning of September 2023. Diabetic Supplies’ revenue for the last twelve months per June 30, 2023, amounted to USD 8.1 million, with an EBITDA of USD 3.3 million, corresponding to an EBITDA margin of 40.4 percent. The acquisition shall be executed at an initial cash

    ADDvise receives order worth USD 4 million

    ADDvise Group AB’s subsidiary MRC Systems FZE has received an order from Tecnimont. The order involves the design endorsement, supply, and installation of multiple cleanroom facilities as part of a larger industrial project. The order is worth approximately USD 4 million. Tecnimont, a subsidiary of Maire, is a leading integrated engineering and construction services and solutions provider for highly complex plants for the natural resources transformation industry. MRC Systems’ scope is covering HVAC (heating and ventilation), electrical works and cleanroom. The estimated project completion

    ADDvise Group recruits Oliver Humlen as new CFO

    ADDvise recruits Oliver Humlen as new CFO and member of the executive management team. Oliver has more than a decade of experience from investment banking. He joins ADDvise from Pareto Securities where he has been working within Debt Capital Markets for the past nine years, of which six as Partner. Prior to that, he worked with Mergers and Acquisitions at Barclays in London. Oliver has a BSc in Business Management from King’s College, London. He will commence his employment no later than September 18, 2023. -          We are excited about this recruitment which will strengthen our

    Interim report 2023, January 1-June 30

    April-June 2023 Net revenue for the period was SEK 344.4 million (231.9), an increase of 48.5%. Organic growth was 10.4%. Orders received for the period was SEK 319.3 million (260.9), an increase of 22.4%. Organic growth was 15.7%. EBITDA for the period was SEK 121.6 million (34.3) Profit/loss for the period was SEK 3.2 million (19.1) Earnings per share for the period amounted to SEK 0.02 (0.11) Cash flow from Operations for the period was SEK 102.2 million (20.3) Updated 2023 forecast, SEK 500 million EBITDA pro forma and SEK 1.7 billion net revenue pro forma

    ADDvise announces preliminary results for Q2 2023 that are stronger than expected

    The preliminary results for ADDvise Group for the second quarter of 2023 significantly deviate from what ADDvise assesses as the market expectations. SEK million Q2 2023 Q2 2022  LTM June 2023Net sales 342.7 231.9 1,206.0Gross profit 232.9 139.9 768.0Gross margin % 68.0% 60.3% 63.7%EBITDA 121.0 34.3 333.7EBITDA margin % 35.3% 14.8% 27.7%EBITA 90.3 30.1 278.2EBITA margin % 26.3% 13.0% 23.1%   The financial targets for the full year 2023, as previously communicated, are a pro forma

    Invitation to presentation of interim report April 1 – June 30, 2023

    Stockholm, July 6, 2023 Invitation to presentation of interim report April 1 – June 30, 2023   Media, investors and analysts are on the same day invited to attend a presentation of the interim report April 1 – June 30, 2023 at July 20 13:00 (CEST), 07:00 AM (EST). The CEO, Rikard Akhtarzand, will present the report in a webcast and telephone conference.   Webcast If you wish to participate via webcast, please use the link below. Via the webcast you can ask written questions. https://ir.financialhearings.com/addvise-group-q2-2023/register   Conference call If

    ADDvise publishes prospectus and applies for admission to trading of bonds on Nasdaq Stockholm

    On May 26, 2023, ADDvise Group AB (publ) (“ADDvise”) successfully issued senior secured bonds in an initial amount of SEK 1,000 million, under a total framework of SEK 2,000 million (the “Bonds”).Pursuant to the terms and conditions for the Bonds, ADDvise has undertaken to apply for admission to trading of the Bonds on the corporate bond list of Nasdaq Stockholm. For this purpose, the company has prepared a listing prospectus, which today has been approved by the Swedish Financial Supervisory Authority (Sw. Finansinspektionen). The prospectus is available at the company’s website www.

    ADDvise signs Letter of Intent to acquire Innovative Endoscopy Components, LLC.

    ADDvise has signed a Letter of Intent with the shareholders of Innovative Endoscopy Components, LLC. (”IEC”) regarding an acquisition of all shares in IEC. IEC is an international provider of endoscopy equipment and endoscopy spare parts based in Fort Lauderdale, Florida, USA. The company manufactures, supplies and repairs OEM and aftermarket parts to the endoscopy industry with customers in over 100 countries. The company’s revenue for the last twelve months as of May 31, 2023 amounted to USD 9.4 million with an EBITDA of USD 1.7 million, corresponding to an EBITDA margin of 18.4

    ADDvise announces that the conditions for the early redemption of existing bonds 2021/2024 have been fulfilled

    ADDvise Group AB (publ) (the “Company”) announced on 12 May 2023 that it will redeem in full all of its outstanding bonds 2021/2024 with ISIN SE0015222088 (the “Bonds” and “Early Redemption”).The Early Redemption was conditional upon the successful issuance of new bonds as announced by the Company through a press release on 11 May 2023 (the “New Bond Issue”). The issue date for the New Bond Issue occurred today and the conditions for the Early Redemption have therefore been fulfilled. The Early Redemption is therefore no longer conditional and will consequently occur on 9 June 2023. The

    ADDvise increases long-term financial targets

    The Board of ADDvise Group AB has decided to update the long-term financial targets for EBITDA margin and revenue growth based on the strong financial performance and the visibility on the upcoming quarters. The EBITDA margin target has been increased from 20% to 28 % and the annual growth target from 25% to 30 %. Growth will be achieved organically as well as through acquisitions. The goal is to maintain consistent organic growth in line with the growth rate of the global healthcare market. -          We have over the last years gradually changed our product mix towards high margin

    ADDvise announces early redemption of existing bonds 2021/2024

    ADDvise Group AB (publ) (the “Company”) announces today that it will redeem in full its outstanding bond loan with ISIN SE0015222088 (the “Bonds” and “Early Redemption”) subject to the successful issuance of new bonds as announced by the Company through a press release on 11 May 2023. Provided that the conditions for Early Redemption are met (which will be announced separately), the Bonds will be redeemed on 9 June 2023 (the “Redemption Date”) at the redemption price of 103.625 per cent. of the nominal amount together with accrued but unpaid interest up to (and including) the Redemption

    ADDvise extends the agreement with Laborie at a value of SEK 48 million

    ADDvise Group’s subsidiary Sonesta Medical AB extends the agreement with Laborie Medical Technologies (“Laborie”). The agreement is giving Laborie the right to sell Sonesta Medical’s urology- and gynecology patient positioning equipment and video fluoroscopy tables worldwide, with an exclusive right to distribute in USA and some European countries. Laborie commits to a minimum volume of SEK 48 million. The term of the agreement is two years. The total value of the orders during the term of the agreement is at least SEK 48 million. Laborie is a leading global developer, manufacturer and

    ADDvise issues senior secured bonds

    ADDvise Group AB (publ) (the “Company”) announces today that it has successfully placed senior secured bonds in an amount of SEK 1,000 million under a framework of SEK 2,000 million with a tenor of 3 years (the “New Bonds” or the “Bond Issue”). The New Bonds will carry floating rate interest of STIBOR 3m plus 5.50 per cent per annum and were issued at par. The issue date for the New Bonds is expected to be 26 May 2023. The Bond Issue saw strong demand from a broad base of Nordic and international institutional investors and was significantly oversubscribed. Pareto Securities AB acted as

    ADDvise signs Letter of Intent to acquire Kolplast CI S.A.

    ADDvise has signed a Letter of Intent with the shareholders of Kolplast CI S.A. (”Kolplast”) regarding an acquisition of all shares in Kolplast. Kolplast is a Brazilian manufacturer of MedTech equipment based in São Paulo, Brazil. The company produces disposable medical devices, MedTech equipment, laboratory equipment, and liquid-based cytology products. The company is the market leader in Brazil with over 8,000 active clients. Several of the company’s products are registered for sale in the US and Europe. The company’s revenue for the full year 2022 amounted to BRL 100.3 million with

    There are no items matching the current filter
    There are no more items matching the current filter
    Back to top

    Subscribe